These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2547647)

  • 1. The molecular genetics of human lung cancer.
    Slebos RJ; Rodenhuis S
    Eur Respir J; 1989 May; 2(5):461-9. PubMed ID: 2547647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
    Bergh JC
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
    Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
    Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.
    Schneider PM; Hung MC; Chiocca SM; Manning J; Zhao XY; Fang K; Roth JA
    Cancer Res; 1989 Sep; 49(18):4968-71. PubMed ID: 2569928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
    Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
    Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oncogenes and tumour suppressor genes in human lung carcinogenesis.
    Harris CC; Reddel R; Pfeifer A; Iman D; McMenamin M; Trump BF; Weston A
    IARC Sci Publ; 1991; (105):294-304. PubMed ID: 1855868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
    Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
    Kiefer PE; Bepler G; Kubasch M; Havemann K
    Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology of lung cancer and its clinical relevance.
    Cagle PT
    Monogr Pathol; 1993; (36):134-44. PubMed ID: 7906382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
    Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
    Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular and cellular basis of human lung cancer.
    Gazdar AF
    Anticancer Res; 1994; 14(1B):261-7. PubMed ID: 8166465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.
    Rodenhuis S; van de Wetering ML; Mooi WJ; Evers SG; van Zandwijk N; Bos JL
    N Engl J Med; 1987 Oct; 317(15):929-35. PubMed ID: 3041218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of lung cancer and potential translational applications.
    Minna JD; Fong K; Zöchbauer-Müller S; Gazdar AF
    Cancer J; 2002; 8 Suppl 1():S41-6. PubMed ID: 12075701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of non-small cell lung cancer. New diagnostic approaches.
    Linnoila I
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1027-51. PubMed ID: 1962774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular abnormalities in lung cancer.
    Salgia R; Skarin AT
    J Clin Oncol; 1998 Mar; 16(3):1207-17. PubMed ID: 9508209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.